277 related articles for article (PubMed ID: 16826310)
21. Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.
Conterno LO; Silva Filho CR; Rüggeberg JU; Heath PT
Cochrane Database Syst Rev; 2006 Jul; (3):CD001834. PubMed ID: 16855979
[TBL] [Abstract][Full Text] [Related]
22. Expanding prevention of invasive meningococcal disease.
Pelton SI; Gilmet GP
Expert Rev Vaccines; 2009 Jun; 8(6):717-27. PubMed ID: 19485753
[TBL] [Abstract][Full Text] [Related]
23. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination.
Trotter CL; Gay NJ; Edmunds WJ
Am J Epidemiol; 2005 Jul; 162(1):89-100. PubMed ID: 15961591
[TBL] [Abstract][Full Text] [Related]
24. Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.
Hepkema H; Pouwels KB; van der Ende A; Westra TA; Postma MJ
PLoS One; 2013; 8(5):e65036. PubMed ID: 23741448
[TBL] [Abstract][Full Text] [Related]
25. Meningococcal polysaccharide-protein conjugate vaccines.
Snape MD; Pollard AJ
Lancet Infect Dis; 2005 Jan; 5(1):21-30. PubMed ID: 15620558
[TBL] [Abstract][Full Text] [Related]
26. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
LaForce FM; Djingarey M; Viviani S; Preziosi MP
Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
[TBL] [Abstract][Full Text] [Related]
27. The Changing Epidemiology of Meningococcal Disease.
Cohn A; MacNeil J
Infect Dis Clin North Am; 2015 Dec; 29(4):667-77. PubMed ID: 26610420
[TBL] [Abstract][Full Text] [Related]
28. WITHDRAWN: Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.
Conterno LO; da Silva Filho CR; Ruggeberg JU; Heath PT
Cochrane Database Syst Rev; 2011 Jul; 2011(7):CD001834. PubMed ID: 21735387
[TBL] [Abstract][Full Text] [Related]
29. Evolving meningococcal immunization strategies.
Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
[TBL] [Abstract][Full Text] [Related]
30. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
Trotter CL; Ramsay ME
FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998
[TBL] [Abstract][Full Text] [Related]
31. The epidemiology of meningococcal disease and the impact of vaccines.
Khatami A; Pollard AJ
Expert Rev Vaccines; 2010 Mar; 9(3):285-98. PubMed ID: 20218857
[TBL] [Abstract][Full Text] [Related]
32. Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil.
Cardoso CW; Pinto LL; Reis MG; Flannery B; Reis JN
Vaccine; 2012 Aug; 30(37):5541-6. PubMed ID: 22749604
[TBL] [Abstract][Full Text] [Related]
33. Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987-2013.
Husain EH; Barakat M; Al-Saleh M
J Infect Public Health; 2015; 8(5):441-7. PubMed ID: 25779346
[TBL] [Abstract][Full Text] [Related]
34. Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification.
Garrido-Estepa M; León-Gómez I; Herruzo R; Cano R
Vaccine; 2014 May; 32(22):2604-9. PubMed ID: 24662700
[TBL] [Abstract][Full Text] [Related]
35. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
Yogev R; Tan T
Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
[TBL] [Abstract][Full Text] [Related]
36. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
[TBL] [Abstract][Full Text] [Related]
37. Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.
Deeks ED
Paediatr Drugs; 2012 Feb; 14(1):63-5. PubMed ID: 22149552
[No Abstract] [Full Text] [Related]
38. Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project.
Soriano-Gabarró M; Rosenstein N; LaForce FM
J Health Popul Nutr; 2004 Sep; 22(3):275-85. PubMed ID: 15609780
[TBL] [Abstract][Full Text] [Related]
39. An evaluation of emerging vaccines for childhood meningococcal disease.
Choudhuri D; Huda T; Theodoratou E; Nair H; Zgaga L; Falconer R; Luksic I; Johnson HL; Zhang JS; El Arifeen S; Nelson CB; Borrow R; Campbell H; Rudan I
BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S29. PubMed ID: 21501447
[TBL] [Abstract][Full Text] [Related]
40. Global practices of meningococcal vaccine use and impact on invasive disease.
Ali A; Jafri RZ; Messonnier N; Tevi-Benissan C; Durrheim D; Eskola J; Fermon F; Klugman KP; Ramsay M; Sow S; Zhujun S; Bhutta Z; Abramson J
Pathog Glob Health; 2014 Jan; 108(1):11-20. PubMed ID: 24548156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
